维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="FLECK P R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and tolerability of the DPP4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type-2 diabetes 显示文摘	DEFRONZO R A BURANT C F FLECK P	2012	J Clin Endocrinol Metab2012，97，5：	1
2	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type-2 diabetes: a randomized, double-blind, placebo-controlled study 显示文摘	PRATLEY R E REUSCH J E FLECK P R	2009	Curr Med Res Opin2009，25，10：	1
3	Cardiovascular safety of the dipeptidyl peptidase-4 inhibitor alogliptin in type-2 diabetes mellitus 显示文摘	WHITE W B PRATLEY R FLECK P	2013	Diabetes Obes Metab2013，15，7：	1
4	Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to met- formin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, ran- domised, double-blind, placebo-controlled study显示文摘	Nauck M A Ellis G C Fleck P R	2009	Int J Clin Pract2009，63，1：	1
5	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy显示文摘	Pratley R E ipnes M S Fleck P R etal	2009	Diabetes Obes Metab2009，11，2：	1
6	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study显示文摘	Pratley R E Reusch J E B Fleck P R	2009	Current Medical Research and Opinion2009，25，10：	1
7	A computational and experimental study of the scavenging flow in the transfer duct of a motored two-stroke cycle engine显示文摘	Creaven J P Kenny R G Fleck R	2001	Journal of Automobile Engineering2001，215，9：	1
8	Laser Doppler ve- locimetry measurements of flow within the cylinder of a motored two-stroke cycle engine-comparison with some computational fluid dynamics predictions显示文摘	Creaven J P Fleck R Kenny R G	2003	International Journal of Engine Research2003，4，2：	1
9	Is parental rearing an associated factor of quality of life in adulthood 显示文摘	Zmmerm Ann J J Elsemann M R Fleck M P	2008	Qual Life Res2008，17，2：	1
10	Efficacy and safety of alogliptin monotherapy over 12 weeks in patients with type 2 diabetes 显示文摘	Fleck P Christopher R Covington P	2008	Diabetes2008，57，1：	1
11	Die aktivlenkung: das dynamische lenksystem des neuen 5er 显示文摘	KOHN P PAULY A FLECK R	2003	Sonderausgabe von ATZ/MTZ2003，，8：	1
12	Cardiovascular safety of the dipeptidyl peptidase- 4 inhibitor alogliptin in type 2 diabetes mellitus显示文摘	White WB Pratley R Fleck P	2013	Diabetes Obes Metab2013，15，7：	1
13	High-level semi-synthetic production of the potent antimalarial artemisinin显示文摘	Paddon C J Westfall P J Pitera D J Benjamin K Fisher K Mcphee D Leavell M D Tai A Main A Eng D Polichuk D R Teoh H Reed D W Treynor T Lenihan J Fleck M Bajad S Dang G Dengrove D Diola D Dorin G Ellens K W Fickes S Galazzo J Gaucher S P Geistlinger T Henry R Hepp M Horning T Iqbal T Jiang H Kizer L Lieu B Melis D Moss N Regentin R Secrest S Tsuruta H Vazquez R Westblade L F Xu L Yu M Zhang Y Zhao L Lievense J Covello P S Keasling J D Reiling K K Renninger N S Newman J D	2013	Nature2013，496，7446：	1
14	Efficacy and safety of the dipeptidyl peptidase - 4 inhibitor alogliptin in patients with type 2 diabe- tes inadequately controlled by glyburide monotherapy 显示文摘	Prattey R E Kipnes M S Fleck P R	2009	Diabetes Obes Metab2009，11，2：	1
15	Leavening cells viability in frozen French bread dough显示文摘	Kechinski C P Castro M G Fleck R J	2010	Ciencia Rural2010，40，11：	1
16	Alogliptin use in elderly peo- ple: a pooled analysis from phase 2 and 3 studies 显示文摘	Pratley R E McCall T Fleck P R	2009	J Am Geriatr Soc2009，57，11：	1
17	Cardiovascular safety of the dipeptidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus显示文摘	White WB Pratley R Fleck P	2013	Diabetes Obes Metab2013，15，：	1
18	High-level semi-synthetic production of the potent antimalarial artemisinin 显示文摘	Paddon C J Westfall P J Pitera D J Benjamin K Fisher K Mcphee D Leavell M D Tai A Main A Eng D Polichuk D R Teoh K H Reed D W Treynor T Lenihan J Fleck M Bajad S Dang G Dengrove D Diola D Dorin G Ellens K W Fickes S Galazzo J Gaucher S P Geistlinger T Henry R Hepp M Horning T Iqbal T Jiang H Kizer L Lieu B Melis D Moss N Regentin R Secrest S Tsuruta H Vazquez R Westblade L F Xu L Yu M Zhang Y Zhao L Lievense J Covello P S Keasling J D Reiling K K Renninger N S Newman J D	2013	Nature2013，496，7446：	1
19	Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes 显示文摘	DeFronzo R A Burant C F Fleck P	2012	97 (5) :16152012，97，5：	1
20	Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus显示文摘	white wB Pratley R Fleck P	2013	Diabetes Obes Metab2013，15，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示